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Abstract  
The formation of blood vessels is a complex tissue-specific process that plays a pivotal role during 
developmental processes, in wound healing, cancer progression, fibrosis and other pathologies. To study 
vasculogenesis and vascular remodeling in the context of the lung, we developed an in vitro 
microvascular model that closely mimics the human lung microvasculature in terms of 3D architecture, 
accessibility, functionality and cell types. Human pericytes from the distal airway were isolated and 
characterized using flow cytometry. To assess their role in the generation of normal microvessels, lung 
pericytes were mixed in fibrin gel and seeded into well-defined micro-compartments together with 
primary endothelial cells (HUVEC). Patent microvessels covering an area of 3.1 mm2 formed within 3-5 
days and were stable for up to 14 days. Soluble signals from the lung pericytes were necessary to 
establish perfusability, and pericytes migrated towards endothelial microvessels. Cell-cell communication 
in the form of adherens and tight junctions, as well as secretion of basement membrane was confirmed 
using transmission electron microscopy and immunocytochemistry on chip. Direct co-culture of pericytes 
with endothelial cells decreased the microvascular permeability by one order of magnitude from 17.8∙10-
6 cm/s to 2.0∙10-6 cm/s and led to vessels with significantly smaller and less variable diameter. Upon 
phenylephrine administration, vasoconstriction was observed in microvessels lined with pericytes but 
not in endothelial microvessels only. Perfusable microvessels were also generated with human lung 
microvascular endothelial cells and lung pericytes. Human lung pericytes were thus shown to have a 
prominent influence on microvascular morphology, permeability, vasoconstriction and long-term 
stability in an in vitro microvascular system. This biomimetic platform opens new possibilities to test 
functions and interactions of patient-derived cells in a physiologically relevant microvascular setting. 
 
Key words: vasculogenesis, vascular remodeling, paracrine signaling, 3D cell culture, biomimetic in vitro 
models, lung microvasculature  
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Introduction 
The assembly and remodeling of vascular structures is highly important during fetal development, 
wound healing and cancer progression1,2. Vascular dynamics also plays a key role in numerous diseases in 
a tissue-specific manner. In pulmonary arterial hypertension (PAH) for example, vascular remodeling and 
vasoconstriction of the lung microvasculature lead to an increased pulmonary vascular resistance, 
decreased vessel compliance and consequently hypertension3. Although some mechanisms that alter the 
vasculature, such as excessive pericyte proliferation4 and calcium sensitization have recently been 
identified, the complex interplay between endothelial cells and pericytes and their combined effects on 
disease progression are still incompletely understood5. Angiogenesis is also believed to play a key role in 
idiopathic pulmonary fibrosis (IPF), an aggressive and usually fatal disease6. IPF not only damages the 
alveolar architecture but also affects the pulmonary microvasculature. However, the role of pulmonary 
angiogenesis in the fibrotic lung, in particular on the temporal and spatial heterogeneity of de novo 
vascularization and vascular degradation, remains controversial7. 
Advanced in vitro systems that closely mimic the conditions of the human lung are one strategy amongst 
many to increase our understanding of pulmonary vasculogenesis and vascular remodeling. Recently, 
several in vitro models have been developed that reproduce vascular structures. The group of Stroock 
micropatterned Collagen I gel and lined the 100 μm wide lumens with endothelial cells8. These vascular 
structures were stable and perfusable, but vascular remodeling was limited due to a high gel stiffness. A 
different approach was taken by Moya et al.9, who used the vasculogenic properties of endothelial cells 
under shear stress to initiate vessel formation. Yet another method exploited the natural microvessel 
formation of endothelial cells inside fibrin gel by providing appropriate growth factors and signals from 
fibroblasts10,11.  
These novel models mimic the cellular microenvironment much better than standard in vitro assays 
performed in static conditions. Endothelial cells attach to and modify a 3D meshwork to form perfusable 
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microvessels and with the addition of perivascular cells or physiologic interstitial flow further approach in 
vivo-like conditions. Specifically, perivascular support cells, either fibroblasts9,10 or mesenchymal stem 
cells12, were shown to positively impact vessel orientation and stabilization, representing inherent 
functions performed by mural cells in vivo. However, in the micovasculature of the lung and organs such 
as the brain and kidney, pericytes are the main mural cells and are present also around pulmonary 
capillaries13. Apart from their location in the basal membrane around endothelial microvessels, pericytes 
are identified by surface markers such as NG2, CD146, 3G5, αSMA and PDGFRβ14. Pericytes are key 
players during vessel morphogenesis and in controlling vessel stabilization, remodeling and tightness. 
Two recent studies have linked abnormal pericyte coverage to the progression of human PAH4 and 
pulmonary fibrosis15 respectively, underlining their functional importance in the lung microvasculature. 
Here, our objective was to identify and assess the functional role of primary human lung pericytes and 
endothelial cells in a microfluidic platform for perfusable microvasculature. In a first phase, the various 
parameters of the in vitro model were established using primary human lung pericytes co-cultured with 
endothelial cells from the umbilical vein. In a second step, primary human lung microvasculature cells 
were used to more faithfully mimic  the lung microvascular environment. Vasculogenesis and pericyte 
recruitment were observed over days and direct cell-cell interactions were imaged in high resolution. 
The effects of the pericytes on endothelial cells were investigated using two co-culture strategies, by 
seeding these cells in direct contact or in spatially separated but communicating compartments. Our 
results show that the direct presence of pericytes around the microvasculature has a dramatic effect on 
vessel morphology, permeability, and vasoconstriction.   
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Materials and Methods 
Device design and fabrication 
A 100 μm high microfluidic device with five compartments separated by trapezoidal micropillars with 
100 μm spacing was designed, based on a design reported by Jeon et al.10. Unlike the aforementioned 
system, the central chamber of the chip was round and wider (2 mm diameter with a central pillar for 
stability), the adjacent flow channels were 1 mm wide and the outermost chambers 0.5 mm wide. 
Standard photolithography was used to pattern the microstructures with negative photoresist (GM-
1070, Gersteltec) on Si-wafers. Polydimethylsiloxane (PDMS, Sylgard) was mixed at a 10:1 ratio with 
curing agent, casted on the mold and cured for at least two hours at 80°C. Chips were cut, access ports 
for gel loading punched with 0.5 mm biopsy punches (Shoney Scientific) and reservoirs with 5 mm 
punches (AEP Medicalcare). Finally, cleaned chips and standard glass cover slips were activated in oxygen 
plasma (Harrick Plasma Cleaner) at 650 mTorr for 25 seconds, bonded together and baked overnight at 
60°C before use. 
Cell culture 
Primary human umbilical cord vein endothelial cells (HUVEC PCS-100-010, ATCC) were cultured on 0.1% 
gelatin-coated flasks in EGM-2 cell culture medium (Lonza). Primary human lung microvascular 
endothelial cells (HMVEC-L, Lonza) were cultured on 0.1% gelatin-coated flasks in EGM-2MV cell culture 
medium (Lonza). Cells between passage 3 and 6 were used for experiments. 
Isolation of lung pericytes 
To prospectively isolate lung pericytes, we used lung specimens obtained from patients following 
surgical resection for lung cancer. Normal tissue was procured from the lung specimen at a distant site of 
the tumor foci. All patients gave informed written consent for usage of surgical material for research 
purposes, which was approved by Ethics Commission of the Canton of Bern, CH.  
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Preparation of lung tissue and cell sorting was performed as previously described with modifications16. 
Briefly, normal appearing lung tissue was resected from the tumor foci at a distance > 5 cm. and digested 
using a solution of collagenase I and II (Worthington Biochemical Company). Digestion of lung tissue was 
halted following the addition of 10% FBS (Invitrogen).  Single cells were stained with a panel of 
fluorescently conjugated human monoclonal antibodies directed at the following epitopes: CD45-PB 
(eBioscience), CD14-PB (eBioscience), CD31-PB (eBioscience), CD235a-PB (eBioscience), CD73-APC 
(eBioscience) and CD90-FITC (eBioscience). To exclude dead cells, 7-AAD was added prior to sorting. Cells 
were sorted using a BD FACS Aria III and were directly cultured in a 6-well tissue culture plate pre-coated 
with 0.1% gelatin in alpha-MEM (Sigma) supplemented with 1% FBS (Gibco), 20 ng/mL of recombinant 
human FGF2 (Gibco), 25 ng/mL of recombinant human EGF (Gibco), 1.25 mg of human Insulin (Sigma), 
1% pen-strep (Sigma). Cells were grown at 37°C, 5% CO2 and low O2 (3%) until reaching confluence and 
used up to passage 6. Bone marrow-derived mesenchymal stem cells (BM-MSCs) were isolated using the 
same antibody and panel as described above. 
Cell characterization 
Following expansion, FACS sorted lung pericytes or BM-MSCs were harvested and re-suspended in FACS 
staining buffer. Cells were incubated with antibodies on ice and protected from light for 30 minutes. 
Following staining, cells were washed and resuspended in PBS. Cells were incubated with the following 
fluorescently conjugated human monoclonal antibodies: PDGFRα-biotin (eBioscience), CD105-FITC 
(eBioscience), NG2-FITC (eBioscience), CD146-PE (eBioscience), CD61-APC (eBioscience) and CD44-APC 
(eBioscience). For analysis of PDGFRα, cells were stained with streptavidin labelled APC-Cy7 
(eBioscience). 7-AAD was added to exclude dead cells and debris. Cell acquisition was performed using a 
BD FACS LSRII. For analysis, 30,000 events were collected and analyzed using FlowJo software version 
10.7 (Treestar).  
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For TGF-β1 treatment, lung pericytes and BM-MSCs were seeded in 8-well chamber slides. Cells were 
treated with 10ng/ml of TGF-β1 (eBioscience) for 3 consecutive days. Thereafter, the cells were washed 
twice with PBS, fixed with 4% Paraformaldehyde (Sigma) for 15 minutes, washed with PBS and blocked in 
a 2% BSA solution (Sigma) for 1h. Then, the cells were stained with Phalloidin-TRITC (Invitrogen) and 
αSMA-FITC (Sigma) and nuclei were counterstained with DAPI for 2h at room temperature. After washing 
with PBS, the chamber slides were imaged on a Leica DMI 4000 microscope (10x and 20x objectives). 
Chip loading and maintenance 
Chips were sterilized under UV for 2h or in an ozone chamber (CoolCLAVE) prior to loading. ECs and Lung 
pericytes were resuspended in 2 U/ml thrombin from bovine plasma (Sigma) in EGM-2 at a final 
concentration of 2∙107 cells/ml (HUVEC), 1∙108 cells/ml (HMVECL) and 1∙107 cells/ml respectively. For 
combined co-culture, the EC and lung pericyte thrombin-suspensions were mixed at a 1:1 ratio, resulting 
in 1∙107 HVUEC/ml, 5∙107 HMVECL/ml and 0.5∙107 Lung pericytes/ml. Fibrinogen from bovine plasma 
(Sigma) was dissolved in deionized PBS (Gibco) to a concentration of 5 mg/ml. In a separate tube, a 
clotting test with 2 U/ml thrombin in EGM-2 and 5 mg/ml fibrinogen solution was carried out to confirm 
clotting of the mixture after 5 minutes at room temperature. The HUVEC-thrombin suspension was then 
mixed with 5 mg/ml fibrinogen at a ratio of 1:1 and immediately pipetted into the central chamber. The 
solution stayed in the central chamber due to liquid pinning between micropillars. Five minutes later, the 
lung pericyte-thrombin suspension was mixed at a 1:1 ratio with the fibrin solution and injected into the 
outer chambers. After complete gelation in all chambers (10 minutes), EGM-2 was pushed through the 
flow channels and reservoirs were filled. The chips were incubated at 37°C and 5% CO2 in petri dishes 
with a moist tissue for humidification. Cell culture medium was exchanged after 24h and then every 48h 
by emptying all four reservoirs. The reservoirs were filled with medium in order to create a transient 
pressure drop across the central chamber with an initial pressure head of 1.3 mm. This hydrostatic 
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pressure enhanced medium supply to the cells in the central chamber. Chips were kept in culture for up 
to 14 days. 
Immunostaining 
The chips were washed twice with PBS, fixed with 4% Paraformaldehyde (Sigma) for 15 minutes, and 
washed three times with PBS. If intracellular markers were used, 0.1% Triton X-100 (Sigma) was applied 
for 10 minutes and washed away 3x with PBS. After 1h of blocking in a 2% BSA (Sigma) solution, primary 
antibodies VE-Cadherin (SantaCruz), Collagen IV (Abcam), PECAM-1 (Santa Cruz), αSMA (Novus 
Biological), ZO-1 (Invitrogen)) were incubated overnight at 4°C. Subsequently, devices were washed 
three times with PBS and incubated with Alexa-fluorophore coupled secondary antibodies (Molecular 
Probes), as well as Phalloidin (1:100, Invitrogen) and Hoechst (1:1000, Invitrogen) for 2 hours at room 
temperature. After final washings with PBS, the chips were imaged on a Zeiss confocal LSM 710 
microscope (10x, 20x and 40x objectives). 
Time-lapse observation  
For time-lapse observations and imaging of endothelial-pericyte interactions, the cells were labeled with 
lipophilic cell tracker dyes PKH67 green (HUVECs) and PKH26 red (lung pericytes) prior to seeding. The 
devices were loaded into the Nikon Biostation CT and imaged every hour with the 4x magnification in 
brightfield, red and green fluorescence. Cell culture medium was replaced every 48h. 
Vascular area and perfusability quantification  
To characterize the vascular networks, z-stacks (10 slices covering a 100 μm depth) of tile scans (2.4 x 2.4 
mm) of the central chamber were analyzed using the open source image analysis software Fiji 
(http://fiji.sc/Fiji). The vascularized areas were defined as being phalloidin-positive (separated co-
cultures in Fig.5A and B) and PECAM -1 positive (direct co-cultures in Fig.7A). The phalloidin or PECAM-1 
signals were quantified from the entire central chamber. The z-stacks were projected on a single plane 
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and binarized with the automatic triangle thresholding method. The binary operation “close”, and outlier 
removal were applied to remove small unconnected particles. “Analyze particles” was used to quantify 
the vascularized area inside the central chamber. Only areas larger than 100 μm in diameter were taken 
into account to determine the vascularized area percentage. The number of perfusable entrances was 
assessed visually by checking openings in 3D images obtained with the confocal microscope. Each cell 
culture condition experiment was repeated three to six times. Average values with standard deviations 
are reported. Results were compared using a two-tailed Student t-test.  
For measurements of the minimal and maximal diameters, the width of three of the smallest and three 
of the largest vascular segments (perpendicular to the vessel wall) was measured on tile-scans of PKH26-
labeled microvessels by using the line and measurement command in Fiji. The mean value and standard 
deviation of six chips are reported. 
Electron microscopy 
The chips were fixed in 2.5% glutaraldehyde (Agar Scientific) in 0.15M HEPES buffer overnight (total 
osmolarity: 696 mOsm, pH 7.35), and postfixed for 1 hour in a 1% solution of osmium tetroxide (Electron 
Microscopy Sciences) in 0.1 M sodium cacodylate buffer (total osmolarity: 369 mOsm, pH 7.40). After 
rinsing in 0.05 M maleate buffer (pH 5.0) the chips were dehydrated in increasing concentrations of 
ethanol (70%, 80%, 96%, 100%), passed through acetone and left in a 1:1 mixture of ethanol : epoxy 
embedding medium (Sigma) overnight. On the following day the chips were filled with epoxy embedding 
medium and left to polymerize at 60°C for 4 days. Ultrathin sections (70 nm) were cut on a Reichert-Jung 
ultracut E microtome, put on formvar-coated 2mm x 1mm single slot copper grids and double stained 
with 1% uranyl acetate (Sigma) and 3% lead citrate (Leica Microsystems). Micrographs were taken in a 
Philips EM 400 transmission electron microscope. 
Microbead tracking 
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50 μl of a yellow-fluorescent 1μm polystyrene bead suspension (Polysciences) was added to one of the 
four emptied chip reservoirs, generating a pressure head of 1.3 mm. To track individual beads over time, 
time-lapse images were acquired using a Zeiss confocal LSM 710 at one image per second for five 
minutes and were analyzed with the “TrackMate v2.5.4” plugin in the software Fiji. Bead velocities were 
added as color map to the images.  
Microvessel permeability 
70 kDa Rhodamine isothiocyanate (RITC)-coupled dextran (Sigma) at 1 mg/ml in PBS was added to one 
reservoir. Real-time movies (Panasonic Lumix DMC-LX7) or time-lapse videos (Leica DMI 4000, 1 image 
every 15s) were taken for several minutes. The vascular permeability was calculated as described 
previously17, by measuring fluorescent intensities across vascular segments over time: 
𝑃 =
1
∆𝐼
∙
𝑑𝐼
𝑑𝑡
∙
𝑟
2
 
where ΔI is the initial intensity increase when RITC-dextran is added, (dI/dt) the change of intensity over 
time due to leakage and r/2 the volume to area ratio for a cylindrical segment. Three chips (n=3) were 
measured per condition and 6 – 8 regions were quantified per chip. A two-tailed Welch-corrected 
Student t-test was applied. 
Vasoactive response quantification 
Phenylephrine (Sigma) was dissolved in water (1 mM) and diluted to a concentration of 10 μM in PBS. As 
control, the equivalent amount of water in PBS was used. After staining the microvasculature with 
CellMask Orange (Invitrogen) on day 7, 100 μl of the diluted phenylephrine was added into one empty 
reservoir. A vascular segment was imaged for 5 to 10 minutes (Leica DMI 4000, Cy3, 1 image every 10 
seconds) following drug exposure. The vessel width was assessed over time by measuring the size of a 
vascular segment (perpendicular to the vessel wall), and plotting a kymograph in Fiji (pixel intensities 
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along the line as a function of time). The vessel walls were identified as the two intensity maxima closest 
to the image border. The vessel width at each time point was determined as the distance between the 
two maxima, and normalized to the initial width. Three chips were measured per condition (n=3) and 5 
vessel widths were quantified per chip. Results were compared at each time-point with a two-tailed 
Student t-test. 
Results 
Primary human lung pericyte isolation and characterization 
To address the immunophenotypic identity of human lung pericytes in vivo, we combined multiple 
surface markers to prospectively identify putative lung pericytes. As shown in Figure 1, we identified a 
cluster of non-hematopoietic (negative for CD45 and CD14), non-endothelial (negative for CD31) and 
non-epithelial cells (negative for EpCAM) that were positive for key mesenchymal markers CD73 and 
CD90. When prospectively sorted, these lineage-EpCAM-CD73+CD90+ cells were spindle-shaped 
resembling a pericyte morphology and formed typical CFU-F (Fig.1 lower right. Following expansion, the 
cultured cells were analyzed by multiparameter flow cytometry (Fig.2A) and shown to highly express the 
cell adhesion marker integrin beta-3 (ITGB3, CD61), which is involved in binding extracellular matrix 
proteins. Interestingly, the lung cells demonstrated minimal expression for CD146, a marker found to be 
highly upregulated on BM-MSCs. Further analysis revealed that the ITGB3+ lung cells expressed other 
key pericyte markers NG2 and PDGFRα, whereas on BM-MSCs, PDGFRα was minimally expressed. 
Moreover, putative lung pericytes were positive for CD105 receptor (endoglin) and CD44, the receptor 
for hyaluronic acid. To investigate whether these cells are responsive to the pleiotropic cytokine TGF-β1, 
they were exposed to TGF-β1 for 3 days in culture. TGF-β1 treated cells showed an upregulation in F 
actin stress fibres using the high affinity probe phalloidin and αSMA compared to untreated cells (Fig.2B). 
Together, these results show that the Lin-EpCAM-CD73+CD90+ cells isolated from human lungs match 
the criteria of pericytes, as demonstrated by morphology, the cell surface markers NG24 and PDGFRα18,19 
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and response to TGF-β1. These cells are thus a suitable choice as perivascular supporting cells for an in 
vitro lung microvascular model.  
Direct and indirect co-cultures in the microfluidic chip  
The specific design of the microfluidic chip enabled perfusable microvasculature to form, and to 
investigate the effects of the pericytes on the endothelial vessels (Fig.3). The microvasculature was 
formed inside a 100 μm high central chamber of the chip that was filled with cells and fibrin hydrogel. 
After fibrin polymerization, the two flow channels adjacent to the central chamber were filled with 
physiological medium. The hydrogel/physiological medium interface enabled molecular diffusion of 
nutrients, oxygen and growth factors required for the cells to rearrange and create perfusable vessels. 
Micropillars situated at the perimeter of the central chamber stopped the expansion of the fibrin gel by 
holding the hydrogel in place due to liquid pinning by surface tension (Fig.3C). Two additional 
compartments situated at 1 mm from the central chamber across both flow channels were filled with 
fibrin gel and pericytes. To examine the vasculogenic potential of the lung pericytes, two co-culture 
strategies were investigated. The first strategy consisted of an indirect co-culture approach, in which 
endothelial cells were spatially separated from the lung pericytes. Endothelial cells suspended in fibrin 
solution were seeded into the central chamber, whereas the outer chambers were filled with lung 
pericytes suspended in fibrin solution. The second strategy was based on a direct co-culture of 
endothelial cells and pericytes in the central chamber. In this approach, pericytes were also cultured in 
the outer chambers. In both strategies, cells could migrate from the outer chambers towards the central 
chamber through the hydrogel/physiological medium interfaces or vice versa.  
Lung pericytes support vasculogenesis by paracrine signals 
Following seeding in the central chamber, HUVECs extended towards each other (Fig.4 and Movie S1) 
resulting in vacuole formation, a hallmark of vasculogenesis20,21 (Fig.4B top). The process was dynamic 
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with cells fusing, branching and parting from each other within hours. Vasculogenesis started 
independently from the spatially separated lung pericytes. After 3-5 days, the overall layout of the 
vascular segments stabilized, i.e. the vessel shape did not dramatically change anymore. However, 
sprouting events still occurred (Fig.4B center). Intravascular lumen grew wider and opened up towards 
the flow channels between day 4 and 7. In this setting, vascular structures were kept in culture for at 
least 14 days (Fig.S1).  
Lung pericytes, originally seeded in a separate outer microcompartment, migrated across the flow 
channel towards the central chamber and invaded it within 3-5 days (Fig. 4C bottom and Movie S1). They 
slowly migrated through the fibrin gel of the central chamber and aligned along the microvasculature. 
Importantly, vascular structures only opened up towards the flow channels in the presence of lung 
pericytes in the outer channel (Fig. S2A & B). Cell migration also took place in the opposite direction, 
whereby HUVECs migrated from the central chamber and moved into the flow channels, thus extending 
the vascular structure (Fig.S3).  
In vitro microvessels show typical vascular features and are perfusable 
After seven days of co-culture, patent, interconnected and perfusable microvessels had formed 
throughout the 2 mm wide central chamber. Vessel widths ranged between 20 μm and 220 μm. On 
average, 55.4% ± 11.0% of the central chamber was covered by vascular structures, and 73.5% ± 13.3% 
entrances were opened, connecting  the microvascular network with the flow channels (n = 17) 
(Fig.5A&B). The mean vascularized area percentage obtained from three independent experiments was 
52.0% ± 4.3% (n = 6 chips), 61.1% ± 16.2% (n = 6) and 52.7% ± 7.5% (n = 5). The variation between 
experiments was not significant (p = 0.31), thus the vascular structures formed in a reproducible manner. 
Likewise, the percentage of perfusable entrances was comparable between experiments with 72.2 ± 
8.6% (n = 6), 73.6% ± 19.3% (n = 6) and 75.0% ± 11.8% (n = 5) (p = 0.95). When EGM-2 was replaced only 
every 48h as compared to every 24h, the vascularized area percentage decreased from 63.1% ± 3.2% (n = 
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5) to 52.0% ± 4.3 % (n = 6) (p = 0.001), and there were less perfusable entrances (83.3% ± 5.9% (n = 5) 
compared to 72.2% ± 8.6% (n = 6), p = 0.037) (Fig.5A).  
Immunostainings for VE-Cadherin and PECAM-1/CD31 confirmed the presence of adherens junctions 
between the endothelial cells building the microvessels (Fig.5C). Furthermore, ZO-1 confirmed the 
presence of tight junctions along all vessels. Most importantly, microvessels secreted basement 
membrane components on the basolateral side, as confirmed by collagen IV staining. Tight association 
between the endothelial cells of a microvessel was also confirmed with transmission electron 
microscopy (Fig.5D right). Furthermore, pericytes were only found on the abluminal side, often in close 
contact with the microvasculature (Fig.5D left).  
Perfusability is one of the key features of a functional vasculature. To confirm accessibility of the 
microvessels from the flow channels, a suspension of fluorescent polystyrene microspheres (1 μm 
diameter) was loaded in one reservoir, generating an initial pressure drop of 1.3 mm across the central 
chamber. Indeed, microbeads flowed through accessible vascular segments (Fig.5E and Movie S2). Under 
these flow conditions the mean bead velocity was 6.8 μm/s with minimum and maximum speeds 
comprised between 0 μm/s at the border of the vessels and up to 20 μm/s in the center (Fig. S4). The 
flow path through the microvasculature was also visualized by adding RITC-dextran (Movie S3).  
Direct co-culture with lung pericytes alters vascular morphology, permeability and vasoactive response 
To observe the effects of direct co-culture between lung pericytes and HUVECs, both cell types were 
mixed and seeded in the central chamber. Lung pericytes were also seeded in the outer chambers to 
enable vessel opening. The resulting vessel morphology was strikingly different to the separated co-
culture setting. In direct co-culture (Fig.6A top), vascular diameters were smaller and more streamlined 
as compared to the separated co-culture that had more tortuous vessels (Fig.6A bottom). Indeed, the 
measurements of the smallest and largest diameters were significantly smaller for the direct co-culture 
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than the separated co-culture (p = 0.005 for the smallest and p < 0.001 for the largest diameter, Table 1). 
Vessel diameters were also more narrowly distributed in the direct co-culture (difference from smallest 
to largest diameter 116.7 μm) than the separated co-culture (198.6 μm). Furthermore, immunostaining 
revealed that some pericytes lining the abluminal side of the microvessels highly expressed αSMA 
(Fig.6C). In addition to the morphologic differences, the vascular integrity was also altered. Perfusion 
with 70 kDa RITC-coupled dextran filled the vascular structures, but leaked into the interstitial space in 
the separated co-culture setting (Fig.6B, arrow), whereas no leakage from vessels was obvious in the 
direct co-culture. The calculated permeability coefficients were 17.8∙10-6 cm/s and 2.0∙10-6 cm/s for the 
separated and direct co-culture, respectively (Table 1). Thus, the direct presence of pericytes lowers the 
permeability by a factor of 8 (p = 0.057).   
To assess the physiologic functionality of the pericytes on in vitro microvasculature, we perfused the 
vasoactive α1 adrenergic receptor agonist phenylephrine through microvessels in direct and separated 
co-cultures. The direct presence of pericytes influenced the response to phenylephrine. Microvessels 
with pericyte lining constricted immediately upon phenylephrine administration (p < 0.05 between 120 s 
and 300 s, n = 3 chips per condition) compared to administration of vehicle (Fig. 6E and S5). No 
significant difference between phenylephrine and vehicle was observed in the separated co-culture. 
Microvasculature with primary human lung-derived cells only  
To mimic the microvasculature of the lung more closely, we replaced HUVECs with HMVECLs. Similarly to 
HUVECs, HMVECLs assembled to form continuous microvascular networks, surrounded by and supported 
with lung pericytes. In contrast to direct co-culture of HUVEC and lung pericytes, the seeding ratio for 
HMVECL and lung pericytes needed to be increased from 2:1 to 10:1 to promote perfusable 
microvessels. At lower seeding ratios, the pericytes were more prone to block openings towards the flow 
channel and impede perfusability. Microvasculature made of primary lung-derived endothelial cells and 
pericytes covered 47.74% ± 6.05% of the central chamber area on day 5, and 62.5% ± 14.43% of 
 Page 15 of 44 
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
A
Pr
im
ar
y 
hu
m
an
 lu
ng
 p
er
ic
yt
es
 su
pp
or
t a
nd
 st
ab
ili
ze
 <
i>
in
 v
itr
o<
/i>
 p
er
fu
sa
bl
e 
m
ic
ro
ve
ss
el
s (
do
i: 1
0.1
08
9/t
en
.T
EA
.20
14
.05
45
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
16 
16 
 
entrances were perfusable (n = 4). The vessels expressed PECAM-1 and VE-Cadherin, showed patent and 
perfusable lumen, and pericytes were found on the abluminal vessel side exclusively, in close proximity 
to the endothelial cells (Fig.7).   
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Discussion 
Microfabrication technologies applied to vascular biology open new possibilities to study the fascinating 
processes of vasculogenesis, angiogenesis and vascular remodeling. Not only can such new experimental 
platforms address fundamental questions in vasculogenesis, but they may also be used in the future to 
vascularize tissues prior to implantation22 or optimize drug treatments on personalized vasculature 
models.  
Although several studies recently reported on vasculogenesis on chip9,10, none focused on reproducing 
tissue-specific microvasculature with well-defined cell types. To mimic the microvasculature of the lung 
parenchyma, primary pericytes from human lung parenchyma were used in this study. These cells were 
prospectively sorted from human lung samples using mesenchymal surface markers while being devoid 
of known hematopoietic, endothelial and epithelial markers. The selected cells expressed pericyte-
associated cell surface markers and upregulated αSMA upon stimulation with TGF-β1. Interestingly, 
pericyte surface markers4,14,18 were more highly expressed in the lung pericytes than the BM-MSCs, 
underscoring their specialized function as mural support cells. Taken together, these results confirm that 
the sorted cell type possess phenotypic and functional characteristics known to be found in pericytes. 
To study their role in the context of microvessel assembly and function, the lung pericytes were seeded 
into the microfluidic platform together with endothelial cells. The different seeding options allowed to 
separately observe paracrine and direct-contact interactions of lung pericytes and ECs. Not surprisingly, 
the presence of lung pericytes in the chip was necessary for long-term vessel stabilization21,23,24. Of note, 
it was sufficient to seed the two cell types at 1 mm distance from each other to obtain stable 
vascularization. Over time, both cell types migrated across the separating channel and lung pericytes 
started to wrap around newly formed vascular segments. The influence of lung pericyte signals on vessel 
orientation was evident, because vascular segments only opened up towards the flow channel if 
pericytes were present on the opposing side. This observation shows not only pericyte recruitment 
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during vascular formation but also reorientation of endothelial neo-vessels according to pericyte 
location. The vascular development was also influenced by the growth factors contained in the EGM2 
medium, as shown by the increased area and opened segments when new media was supplied every day 
compared to every second day. 
In addition to the pericyte recruitment towards the vasculature, we also observed dramatic differences 
between the two co-culturing strategies. When lung pericytes and ECs were mixed and co-seeded from 
the outset, pericytes spread around microvascular segments but were never observed inside vessel 
lumens. In this direct-contact setup, microvessels were narrower and less tortuous as compared to 
spatially separated seeding. In addition, vessels with a pericyte lining also showed significantly decreased 
vascular permeability and no leaks in the vessel walls. In fact, pericyte-lined vessel permeability was 
similar to values measured in mammalian venules25, and eight times lower than permeability of vessels 
with ECs only. This effect may be linked to increased basement membrane secretion in the direct contact 
setting26, but this needs to be verified in subsequent studies. This finding is also in line with the 
observation that vessels lacking pericytes are wider, have a more tortuous morphology and are more 
prone to rupture27,28. Moreover, some pericytes in close contact with the microvessels highly expressed 
αSMA, showing a functional response upon direct contact with endothelial cells. Further investigation is 
needed to determine the molecular interaction that leads to this upregulation.  
Administration of phenylephrine demonstrated the vasoconstrictive activity of pericytes, and is 
consistent with reports of pulmonary microvascular contraction upon phenylephrine administration in 
vivo29. We observed slightly smaller values of constriction (3% change in diameter) compared to the 
animal model (6% change in diameter). However, the reported values were measured in small 
pulmonary arterioles (46 m in diameter) whereas our measurements were performed in larger 
endothelial vessels (120 m in diameter) covered by pericytes only, thus the two values are not directly 
comparable. The versatile seeding strategy allowed us to compare the response of vessels made of 
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endothelial cells only and of pericyte-covered endothelial vessels. Interestingly, the former had a slight 
tendency to enlarge upon fluid loading (both with control and phenylephrine administration), in contrast 
to the vessels in direct co-culture. This observation suggests that pericyte-lined microvessels may 
possess a higher stiffness compared to endothelial microvessels alone. Taken together, the pericyte 
functions on microvascular morphology, permeability and vasoconstriction known from in vivo 
observations were reproduced in our in vitro platform and demonstrate the physiological relevance of 
our system. 
In the present study, the final microvasculature was perfusable and covered an area of 3.1mm2. 
Importantly, the vascular network formation was highly repeatable and resulted in comparable network 
architecture, despite spontaneous vascular self-assembly. Furthermore, we considered the entire 
vascular area for analyses, not only selected regions of interest. The longevity, reproducibility, and high 
area coverage of the perfusable microvasculature may be of interest for future vascularization studies in 
tissue engineering. In contrast to our results, recent in vitro vasculogenesis assays using spatially 
separated co-cultures did not describe recruitment and direct contact of supporting cells with 
microvessels10,11. This might be due to the shorter experimental duration used in these studies. It is also 
possible that the primary cells used here are more migratory and physiologically relevant as compared to 
the lung fibroblasts reported earlier9,11. In addition, lung resident pericytes might be more specialized in 
stabilizing microvessels than the less differentiated MSCs30.  
Traditional in vitro assays can measure either permeability (cell seeding on a porous insert) or 
vasculogenesis (e.g. cell seeding on matrigel), however, there is no readout for vessel morphology of 
perfusable vessels. In contrast, we can compare vessel morphology, permeability and marker expression 
in the same experiment. This platform is also suitable to perform functional assays that are difficult to 
carry out in animal models. Recording vasoactive responses of the lung microvasculature in vivo is very 
delicate, and only possible with advanced equipment such as a thoracic window combined with intravital 
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videomicroscopy29. In contrast, this readout was straightforward and applicable to human cells in the 
current platform using fluorescent staining and time-lapse microscopy. 
A limitation in our study was the choice of endothelial cells, because HUVECs differ from lung 
microvascular endothelial cells in terms of gene expression, growth, permeability and morphology31,32.To 
further increase resemblance of the current in vitro model to pulmonary microvessels and capillaries, we 
therefore used cells from human lung parenchyma exclusively (HMVEC-L and lung pericytes). We 
demonstrated successful vasculogenesis and the establishment of patent, perfusable microvessels with 
patient-derived endothelial cells and pericytes from the distal airway. In the future, it is conceivable to 
test drugs on such models to optimize individual drug treatments for patients suffering from diseases 
affecting the microvasculature. 
 
Conclusion 
To understand the complex interactions of vascular biology in health and disease, in vitro microvascular 
models must be simple but not reductionist. Here, we developed an in vitro lung microvasculature with 
prospectively sorted primary pulmonary pericytes and endothelial cells in a microfluidic co-culture 
system. Our setup enabled the formation of microvessels that resembled human lung microvasculature 
in terms of 3D morphology, vascular marker expression, ultrastructure, permeability and vasoactive 
response. To further increase the biologic similitude to pulmonary microvessels, human microvascular 
endothelial cells from the lung were seeded together with lung pericytes and built stable and perfusable 
microvascular networks. This simple platform enables building tissue- and patient-specific 
microvasculatures amenable to drug testing or modeling of diseases such as PAH.  
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Table 1 
  
direct 
co-culture 
separated 
co-culture 
Significance test 
p value 
min D (μm) 20.5 (±3.9), n=6 25.6 (±6.0), n=6 0.005 
max D (μm) 137.2 (±31.6), n=6 224.2 (±41.8), n=6 < 0.001 
P (*10-6 cm/s) 2.0 (±1.0), n=3 17.8 (±7.0), n=3 0.057 
 
Table 1 
Comparison of vascular diameter and permeability of direct and separated endothelial-pericyte co-
culture on day 7. 
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Fig. 1 Isolation of Putative Pericytes from Human Lung Tissue 
A subset of small cells was isolated using a 6 antibody/viability marker panel and polychromatic 
fluorescence activated cell sorting. Unfractioned lung cells were initially displayed and gated (R1) on a 
SSC/FSC pseudocolor density plot, which was subgated to discriminate doublets (R2). Single cells (R2) 
were further gated to identify live cells that were negative for the dye 7-AAD (gate R3). These cells were 
subgated onto an antigen plot to display a cluster of lineage negative (Lin-; CD45, CD14, CD31 and 
CD235a) and EpCAM negative cells (gate R4) and Lin-EpCAM+ cells (gate R5). Lin-EpCAM- cells (R4) were 
then displayed as a quadrant gate to identify CD73 and CD90 subset of cells.  Lower right: A 
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representative image of a typical colony forming unit generated from sorted Lin-EpCAM-CD73+CD90+ 
cells obtained from gate R6 and higher power image of single colony (4x).  
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Fig. 2 Lin-EpCAM-CD73+CD90+ Lung Pericyte Characterization 
A) Surface marker expression of Lin-EpCAM-CD73+CD90+ cells (upper panels) compared to bone marrow 
stem cells (BM-MSC, lower panels) by flow cytometry. Representative flow cytometric density plots 
showing both cell types show high expression of CD44 and CD105 (first column). CD146 is highly 
expressed on BM-MSC but not on lung pericytes. In both CD146- and CD146+ populations, NG2 and 
PDGFRα are more highly expressed in lung pericytes than in BM-MSCs. B) Lin-EpCAM-CD73+CD90+ cells 
were expanded in culture and treated with TGF-β1 (10 ng/ml). F-actin and αSMA are upregulated 
compared to vehicle treated cells. Scale bar: 100 μm. 
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Fig. 3 Microfluidic Chip Specifications 
A) View of a microfluidic chip with two microchannel networks filled with food dye for better 
visualization. The channels were microstrucutred in PDMS and bonded on a glass coverslip. B) Chip 
loading with hydrogel and cells in the three compartments for cell culture (blue) and with cell culture 
medium in the two flow channels (red). Dimensions: a: 0.5 mm, b: 2 mm, c: 5 mm, d: 1mm. C) Left: close-
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up view of the central chamber with 0.5mm wide inlet and outlet. Right: illustration of the liquid pinning 
of the fibrin-cell mixture between micropillars of the central compartment. 
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Fig. 4 Vasculogenesis in the Microfluidic Chip 
PKH67 (green)-labeled HUVECs were seeded into the central chamber, and PKH26 (red) labeled pericytes 
were seeded into the side chambers, and vasculogenesis was observed with time-lapse imaging for 7 
days. 
A) View of the central chamber (inside dotted circle) on day 2. Endothelial cells arrange to form tube-like 
structures throughout the central chamber. Scale bar: 500 μm. B) Close-up views of a chip segment, 
focusing on three events during the observation period, interval between images is 1h. Structures of 
interest lie inside the dotted line. Top: sprouting, vacuole formation and lumen fusion of an endothelial 
cell cluster with neighboring cells. Center: sprouting of an existing vessel towards another vessel, 
connection and lumen formation. Bottom: Migration of a pericyte towards a vascular structure. 
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Fig. 5 Microvessel Characterization on Day 7. 
A) Left: Vascularized area and perfusability are reproducible between three independent vasculogenesis 
experiments (p = 0.34, 0.99, 0.45). Right: Replacing the medium every 24h compared to 48h lead to a 
higher vascularized area (p = 0.001) and perfusable entrances (p = 0.037). B) Phalloidin-stained 
microvasculature after seven days in six different chips. The delineation marks the central chamber. 
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Scale bar: 1 mm. C) Microvessels express the adherens junction markers VE-Cadherin and PECAM-1, tight 
junction marker ZO-1 and secrete Collagen IV on the basolateral side. Scale bars: 50 μm. D) Transmission 
electron micrographs show close association of pericytes with the microvessels (left) and junctions 
between two endothelial cells of a microvessel (right). Scale bars: 500 nm. Insets: low-magnification 
views. E) Left: Overlay of time-lapse images show beads moving inside the vascular lumen and follow the 
vessel shape, recording frequency is one image per second. Scale bar: 100 μm. Right: Color-coded tracks 
of individual microbeads inside the microvasculatre according to local velocities (color range: 0 to 20 
μm/s). Note lower velocities close to the vessel borders. Scale bar: 200 μm. 
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Fig. 6 The Direct Presence of Pericytes affects Vessel Morphology, Permeability and Response to 
Phenylephrine. 
Experiments were carried out on day 7 on direct co-cultures (top row) or separated co-cultures (lower 
row). A) Representative images of vascular morphology visualized by PKH26 perfusion shows less 
tortuous vessels when pericytes are directly present. Scale bars: 500 μm. B) Some pericytes in direct 
contact with the microvasculature are αSMA positive. Scale bars: 200 μm C) Perfusion with 70kDA RITC-
labeled dextrane shows focal leaks only in vessels without pericyte coverage (arrow). Scale bars: 100 μm.  
D) Vessel width in response to 10 μM Phenylephrine decreased in case of direct (upper graph) but not 
separated co-culture (lower graph). Mean ± SD of n = 3 chips per condition. 
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Fig. 7 In vitro Human Lung Microvasculature 
A) Direct co-culture of primary human lung endothelial cells and pericytes lead to perfusable 
microvessels on day 5, as shown by PECAM-1 staining and quantification of the vascularized area and 
perfusability (mean ± SD). Scale bar: 500 μm. B) HMVECL microvessels are lined with pericytes. Left: VE-
Cadherin-positive HMVECLs build a microvessel and are surrounded by VE-Cadherin- pericytes. Right: 
Cross-sections through the vessel show tight association of pericytes with the microvessel (arrow). Scale 
bars. 50 μm. 
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Fig. S1 Microvasculature on day 14 
The microvascular network remains intact and viable until day 14, with close endothelial-pericyte 
contacts. HUVEC are stained with PKH67 (green), lung pericytes with PKH26 (red). Scale bars: 500 μm (A), 
100 μm (B). 
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Fig. S2 Four Seeding Strategies with Endothelial Cells and Lung Pericytes on Day 7 
A) Separated co-culture of HUVECs and lung pericytes. Microvascular structures open towards the flow 
channels (inset, the vessel is continuous from the central chamber to the flow channel), and the vessel 
morphology is tortuous. B) Direct co-culture of HUVECs and lung pericytes with pericyte seeding in the 
outer chambers. The microvessels are straighter, and vessels open towards the flow channel (inset). C) 
Direct co-culture of HUVECs and lung pericytes without pericyte seeding in the outer chambers. The 
microvessels are closed upon themselves (inset shows no connection of vessels with the flow channel), 
and dead cells accumulate in the vessel lumen. D) HUVECs only. Microvessels form but regress over days, 
and dead cells accumulate inside closed vessel lumen. Scale bars: 500 μm. 
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Fig. S3 Endothelial and Pericyte Migration into the Flow Channel 
On day 10, the 1mm wide flow channel between the two fibrin chambers is populated with both 
endothelial cells (double positive for VE-Cadherin and Phalloidin) and pericytes (positive for Phalloidin). 
Scale bar: 500 μm. 
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Fig. S4 Microbead Tracking inside the Microvasculature 
A) Color-coded tracks of individual microbeads according to local velocities (color range: 0 to 20 μm/s).  
B) Histogram of the mean velocities recorded over a 5 minute interval. 
 
  
 Page 39 of 44 
Ti
ss
ue
 E
ng
in
ee
rin
g 
Pa
rt 
A
Pr
im
ar
y 
hu
m
an
 lu
ng
 p
er
ic
yt
es
 su
pp
or
t a
nd
 st
ab
ili
ze
 <
i>
in
 v
itr
o<
/i>
 p
er
fu
sa
bl
e 
m
ic
ro
ve
ss
el
s (
do
i: 1
0.1
08
9/t
en
.T
EA
.20
14
.05
45
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
40 
40 
 
 
 
Fig. S5 Vascoactive Response Upon Phenylephrine Administration 
CellMask Orange labeled vasculature on day 7 was perfused with phenylephrine or a control substance. 
Image taken prior to administration (red), overlain with the difference between images 5 minutes after 
administration and t0 (white). A) Direct co-culture. B) Separated co-culture. Scale bars: 100 μm. 
 
Movie S1. Timelapse of vasculogenesis from day 0 to day 7 
HUVECs were stained with PKH67 (green), lung pericytes with PKH26 (red) and seeded in spatially 
separated chambers. Images were taken every hour. 
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Movie S2. Microvessel perfusion with 1 μm beads 
The microvasculature was fixed and stained with Phalloidin on day 10. Yellow-fluorescent microbeads 
were loaded to one reservoir and passed through vascular lumen, showing vessel accessibility from the 
outside. 
 
Movie S3. Microvessel perfusion with RITC-dextran 
The microvasculature was fixed and stained with VE-Cadherin on day 10. RITC-dextran was loaded into 
one reservoir and passed through the vascular lumen, demonstrating vessel tightness. 
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